Patents by Inventor Noa Noy

Noa Noy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8815947
    Abstract: A method of increasing the insulin sensitivity of insulin resistant cells includes administering to the cells an amount of all-trans-retinoic acid effective to activate transcription factor perosixome proliferator-activated receptor (PPAR) ?/? of the cells.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: August 26, 2014
    Assignee: Case Western Reserve University
    Inventor: Noa Noy
  • Publication number: 20120316242
    Abstract: A method of increasing the insulin sensitivity of insulin resistant cells includes administering to the cells an amount of all-trans-retinoic acid effective to activate transcription factor perosixome proliferator-activated receptor (PPAR) ?/? of the cells.
    Type: Application
    Filed: July 3, 2012
    Publication date: December 13, 2012
    Applicant: CASE WESTERN RESERVE UNIVERSITY
    Inventor: Noa Noy
  • Patent number: 8236855
    Abstract: A method of increasing the insulin sensitivity of insulin resistant cells includes administering to the cells an amount of all-trans-retinoic acid effective to activate transcription factor perosixome proliferator-activated receptor (PPAR) ?/? of the cells.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: August 7, 2012
    Assignee: Case Western Reserve University
    Inventor: Noa Noy
  • Patent number: 7759069
    Abstract: Disclosed herein are compositions and methods used for detecting and measuring ligands for nuclear receptors and intracellular lipid binding proteins in both in vitro and in vivo samples.
    Type: Grant
    Filed: December 6, 2005
    Date of Patent: July 20, 2010
    Assignee: Cornell Research Foundation, Inc.
    Inventor: Noa Noy
  • Publication number: 20090137671
    Abstract: A method of increasing the insulin sensitivity of insulin resistant cells includes administering to the cells an amount of all-trans-retinoic acid effective to activate transcription factor perosixome proliferator-activated receptor (PPAR) ?/? of the cells.
    Type: Application
    Filed: May 19, 2008
    Publication date: May 28, 2009
    Inventor: Noa NOY